Design of an N-Methylated Peptide Inhibitor of α-Synuclein Aggregation Guided by Solid-State NMR
- 30 May 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 130 (25), 7873-7881
- https://doi.org/10.1021/ja075356q
Abstract
Many neurodegenerative diseases are associated with the aggregation of misfolded proteins into amyloid oligomers or fibrils that are deposited as pathological lesions within areas of the brain. An attractive therapeutic strategy for preventing or ameliorating amyloid formation is to identify agents that inhibit the onset or propagation of protein aggregation. Here we demonstrate how solid-state nuclear magnetic resonance (ssNMR) may be used to identify key residues within amyloidogenic protein sequences that may be targeted to inhibit the aggregation of the host protein. For α-synuclein, the major protein component of Lewy bodies associated with Parkinson’s disease, we have used a combination of ssNMR and biochemical data to identify the key region for self-aggregation of the protein as residues 77−82 (VAQKTV). We used our new structural information to design a peptide derived from residues 77 to 82 of α-synuclein with an N-methyl group at the C-terminal residue, which was able to disrupt the aggregation of α-synuclein. Thus, we have shown how structural data obtained from ssNMR can guide the design of modified peptides for use as amyloid inhibitors, as a primary step toward developing therapeutic compounds for prevention and/or treatment of amyloid diseases.This publication has 47 references indexed in Scilit:
- β-Sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchangeProceedings of the National Academy of Sciences of the United States of America, 2007
- 3D structure of amyloid protofilaments of β 2 -microglobulin fragment probed by solid-state NMRProceedings of the National Academy of Sciences of the United States of America, 2006
- N-Methylated Peptide Inhibitors of β-Amyloid Aggregation and Toxicity. Optimization of the Inhibitor StructureBiochemistry, 2006
- Solid-state NMR in drug design and discovery for membrane-embedded targetsNature Reviews Drug Discovery, 2005
- Inhibition of fibril formation and toxicity of a fragment of α-synuclein by an N-methylated peptide analogueNeuroscience Letters, 2004
- Mapping Aβ Amyloid Fibril Secondary Structure Using Scanning Proline MutagenesisJournal of Molecular Biology, 2004
- Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicityJournal of Molecular Biology, 2002
- Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformationProceedings of the National Academy of Sciences of the United States of America, 2000
- Aggregates from mutant and wild‐type α‐synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β‐sheet and amyloid‐like filamentsFEBS Letters, 1998
- NACP, A Protein Implicated in Alzheimer's Disease and Learning, Is Natively UnfoldedBiochemistry, 1996